Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

Suabix™ Now Live; Revolutionizing Healthcare with Cutting-Edge AI Human Factors Copilot and Consulting Services for Product Development Teams

Suabix™ Now Live; Revolutionizing Healthcare with Cutting-Edge AI Human Factors Copilot and Consulting Services for Product Development Teams

Suabix™ by Successful Human Factors™, is the first AI Human Factors Copilot for medical product teams, revolutionizing the future of healthcare and patient safety. Successful Human Factors™ is also offering AI integration services tailored to stakeholders needs, powered by Suabix. - May 21, 2024 - Successful Human Factors™

GENINVO Launches Its Latest Offering – DocWrightAI

GENINVO, a leading provider of life science products and business solutions announced the launch of its new, on-demand service: DocWrightAI. GENINVO understands the various challenges in generating clinical documents. The time taken to draft clinical documents with accuracy and compliance has... - May 18, 2024 - GenInvo, Inc.

Novugen Launches Pazopanib Tablets, 200mg, in the U.S. Following ANDA Approval by USFDA

Novugen Launches Pazopanib Tablets, 200mg, in the U.S. Following ANDA Approval by USFDA

Novugen has launched Pazopanib tablets, 200mg, in the U.S. after receiving ANDA approval from USFDA on April 23, 2024. This significant milestone demonstrates Novugen's continued growth in the U.S. pharmaceutical market with a complex anticancer drug, the generic equivalent of Votrient, used to treat advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS). - May 07, 2024 - Novugen

Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease

Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease

AnzuBridge® updates its CDMS to enhance biotech evaluations with advanced video tools, ensuring precise efficacy recording and compliance. It supports scalable trials and features HIPAA-compliant media capture, ePRO for patient engagement, and sophisticated video review capabilities, all integrated with a Learning Management System for efficient trial management. - April 30, 2024 - Anzu

Exploring Growth: API China 2024 Invites Global Visitors and Exhibitors to the Chinese Pharmaceutical Industry

API China, Asia’s premier pharmaceutical trade show, is gearing up for its 90th edition, scheduled to take place from May 15 to 17, 2024, at the prestigious National Exhibition and Convention Center in Shanghai. This year, API China will be collocated with PHARMCHINA and China International... - April 15, 2024 - RX

I Holland Unveils TSAR 2: Advancing Predictive Modelling in Tablet Compression

I Holland proudly announces the development of TSAR 2, an advanced predictive model developed through a collaborative partnership between academia and industry. Building upon the success of the Tabletting Science Anti-Stick Research (TSAR) project, I Holland continues its groundbreaking research... - April 12, 2024 - I Holland Ltd.

Boiron’s New Arnicare® Wellness Kits Offer Holistic Approach to Pain Management

Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and... - April 11, 2024 - Boiron

Huntington Study Group Launches Project AWARE 2.0 Observational Study

Huntington Study Group Launches Project AWARE 2.0 Observational Study

The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group

FuseBio Presents New Data at AACR: Targeting a Functionally-Selective IL-18 (F-18) to PD-1: A Next Generation Checkpoint Inhibitor with Enhanced Anti-Tumor Activity

FuseBio's unique attenuation mechanism renders IL-18, a functionally selective IL-18, resistant to IL-18BP and 1 million percent less active in circulation and yet still retain nearly full activity when targeted to PD-1+/IL-18R+ cells, the key functional immune cells in tumors. It is designed to retain full activity of PD-1 checkpoint blockade and simultaneously deliver a functionally selective IL-18 (F-18) to preserve and enhance the anti-tumor activity of immune cells. - April 09, 2024 - Fuse Biotherapeutics

PocketRN Brings No Cost "Virtual Nurse for Life" to Dementia Patients and Caregivers Under New 8-Year CMS GUIDE Model

PocketRN Brings No Cost "Virtual Nurse for Life" to Dementia Patients and Caregivers Under New 8-Year CMS GUIDE Model

The innovative model enables the expansion of personalized, expert nurse-led care to improve patients’ quality of life and alleviate burden on caregivers nationwide–all with $0 copays. - April 08, 2024 - PocketRN

Geoprise Releases Software to Support New SEC Climate Disclosure Rules

New release to substantially reduce the cost of compliance for most companies. - April 04, 2024 - Geoprise Technologies Corporation

Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare

Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare

New open-source medchat-qa-descriptive dataset enables AI models to provide comprehensive answers to complex medical queries. - March 22, 2024 - ngram Inc.

Bench International Adds Industry Veteran Dr. Renee P. Tannenbaum to Executive Leadership Team

Bench International Adds Industry Veteran Dr. Renee P. Tannenbaum to Executive Leadership Team

Tannebaum Brings Deep Industry Experience in Pharma and Biotech and Board Expertise to Meet Evolving Life Sciences Talent Demands - March 19, 2024 - Bench International

Sabina Ewing Awarded Bench and Deloitte Inaugural Life Sciences  Tech Innovation Award

Sabina Ewing Awarded Bench and Deloitte Inaugural Life Sciences Tech Innovation Award

Award Recognizes Exceptional Contributions by Women in the Life Sciences Industry - March 15, 2024 - Bench International

The University of Iowa Selects TrialX to Build SAYSTOP Study App for a Leading Research Study to Investigate Antibiotics Resistance

The University of Iowa Selects TrialX to Build SAYSTOP Study App for a Leading Research Study to Investigate Antibiotics Resistance

To study a patient-centered approach to antibiotic discontinuation upon symptom resolution in patients with acute uncomplicated pyelonephritis. - March 13, 2024 - TrialX

Innovation in Healthcare: Medical Websites Vie for Coveted Best Medical Website WebAward

Innovation in Healthcare: Medical Websites Vie for Coveted Best Medical Website WebAward

The Web Marketing Association is looking for the best medical websites in the world as part of their 28th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards is the standards-defining competition that sets benchmarks for 90 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites. - March 13, 2024 - Web Marketing Association

Safe Rx Welcomes Lon von Hurwitz as Market Access & Policy Director

Safe Rx Welcomes Lon von Hurwitz as Market Access & Policy Director

Hire Coincides with Growth in Market Access for LPV® Dispensing - March 05, 2024 - Safe Rx

ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials

ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials

The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024 - ALS Therapy Development Institute

IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024

IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024

IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.

GENINVO, a Leading Provider of Life Science Product and Business Solutions Announced the Offering of Its On-Demand Service/Tool: ApoGI™

ApoGI™ is an integrated, one stop automation platform that leverages Artificial Intelligence and Machine Learning algorithms to focus on standards and metadata driven generation of artifacts. The Primary objective of this platform is to help SMEs (Subject matter experts) focus on curating... - February 15, 2024 - GenInvo, Inc.

Biomed Industries Inc. Seeks Collaboration for New Diabetes/Obesity Drug

Biomed Industries, Inc. (Biomed) announced today that it has developed a promising obesity drug, NA-921, which is poised for Phase 2/3 clinical trials. NA-921 is a small molecule drug available in oral formulation. The Company is in discussions with potential partners for collaboration on a Phase... - February 04, 2024 - Biomed Industries Inc.

Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report

New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC

New Sustainable Lyophilization Technology Uses Supercritical CO2

The Thar group of companies have been using CO2 for extraction, purification, particle design and encapsulation for many years but recent developments point to a need for sustainable methods for drying APIs, intermediates, excipients and biologics at relatively low temperatures. 'Big Pharma' has depended on Thar for SFC tools in drug discovery but lyophilization will likely be used in manufacturing too. - January 28, 2024 - Thar Process, LLC

Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues

Creative Diagnostics has announced the launch of its new Robenidine Test Reagents for the detection of robenidine residues. - January 26, 2024 - Creative Diagnostics

HearYou.org and Mark Cuban Cost Plus Drug Company: Pioneering Affordable Mental Health Care

Leaders in Mental Health and Pharmaceutical Pricing Forge Path for Accessible Treatment - January 25, 2024 - Wellness Together

David P. Summers, Ph.D., FACA Honored as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide

Dr. David P. Summers of Montgomery, Texas has been recognized as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of Biomedical Engineering/Pharmacology. About Dr. David P. Summers, PH.D,... - January 11, 2024 - Strathmore Worldwide

Bench International Enters Into Ground Breaking Strategic Alliance with Ashton Tweed

Bench International Enters Into Ground Breaking Strategic Alliance with Ashton Tweed

First of Its Kind Alliance Extends Mutual Service Offerings to Better Serve Clients - January 03, 2024 - Bench International

Empowering Data Privacy: GENINVO Offers Anonymization as a Service

GENINVO, a leading provider of life science product and business solutions announced the offering of its on-demand service Anonymization as a Service. GENINVO a trailblazer in data privacy solutions, is excited to introduce its ground-breaking offering, Anonymization as a Service. With data... - December 14, 2023 - GenInvo, Inc.

FF Biotherapeutics Announces Search for Angel Investment to Revolutionize Immunotherapy and Vaccine Development

FF Biotherapeutics Announces Search for Angel Investment to Revolutionize Immunotherapy and Vaccine Development

FF Biotherapeutics, a pioneering biotech startup at the forefront of immunotherapy and vaccine development, today announced its active pursuit of Angel investment. This critical funding round aims to propel the development of its groundbreaking Synthetic Standardized Convalescent Plasma (SSCP) and... - November 29, 2023 - FF Biotherapeutics

SciCord Informatics Platform R3.0 Boron Release

SciCord is proud to announce a new release of its Cloud-based Laboratory Informatics Platform. - November 22, 2023 - SciCord

Huntington Study Group® Holds 30th Annual Meeting

Huntington Study Group® Holds 30th Annual Meeting

The Huntington Study Group® (HSG®), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently held its 30th annual meeting, HSG 2023, November 2-4 in Phoenix, AZ. Hundreds of scientists, industry partners, HSG research... - November 21, 2023 - Huntington Study Group

Novugen Pharma (USA) LLC Launches ANDA Approved Midodrine 2.5mg, 5mg & 10mg

Novugen Pharma (USA) LLC Launches ANDA Approved Midodrine 2.5mg, 5mg & 10mg

Novugen Pharma (USA) LLC has launched Midodrine 2.5mg, 5mg and 10mg in the U.S. upon the approval from ANDA by FDA. Novugen’s Midodrine will be manufactured in Malaysia by Novugen Pharma Sdn. Bhd. Midodrine is indicated for the treatment of symptomatic orthostatic hypotension, a condition defined as a sudden drop in blood pressure upon standing from a sitting or supine position. - November 07, 2023 - Novugen

Microvascular Therapeutics Receives $3.98M Award from Department of Defense for Its Cardiovascular Product

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a $3.98M FY22 Technology/Therapeutic Development – Funding Level 2 grant from the Congressionally Directed Medical Research Programs (CDMRP). Emmanuelle Meuillet, Chief... - October 18, 2023 - Microvascular Therapeutics, Inc.

Huntington Study Group® Observational Pilot Study Shows HSG’s myHDstory®  Platform Reaches the Unreachable

Huntington Study Group® Observational Pilot Study Shows HSG’s myHDstory® Platform Reaches the Unreachable

The Huntington Study Group® (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc. (HSGCR), a world leader in conducting clinical trials for Huntington’s disease (HD), today announces that the pilot observational study on their innovative online direct-to-patient... - October 16, 2023 - Huntington Study Group

Creative Diagnostics Launches Checkerboard Assay Services

Creative Diagnostics has recently announced the launch of its new Checkerboard Assay services to support researchers. - October 15, 2023 - Creative Diagnostics

Alevea Mental Health Advocates for Psychedelic Therapy, Citing MAPS' Latest Research and Its Own Success with Ketamine Treatment

Alevea Mental Health Advocates for Psychedelic Therapy, Citing MAPS' Latest Research and Its Own Success with Ketamine Treatment

Alevea Mental Health fully endorses psychedelic therapy as an effective mental health treatment, following the recent publication of MAPS' Phase 3 study on MDMA-assisted therapy for PTSD. Alevea has already reported significant success in alleviating symptoms of anxiety, depression, and PTSD through its own Ketamine treatment programs. CEO Topher Bradshaw expressed astonishment at the remarkable patient improvements, particularly when other treatments had failed. - September 20, 2023 - Alevea Mental Health

DEA and Telemedicine: East Coast Telepsychiatry's Push for Modernized Rules

On September 12 and 13, 2023, the DEA discussed telemedicine regulations. East Coast Telepsychiatry's representatives, Pierre Montalvo and Dan Golden, attended in Arlington, VA. Mr. Golden emphasized the importance of telemedicine in prescribing controlled substances. The 2008 Ryan Haight Act's regulations are outdated, prompting the DEA to reconsider after receiving a record of over 38,000 complaints. - September 18, 2023 - East Coast Telepsychiatry

Gotham Biotech's New Histoplasma Urinary Antigen EIA Kit Now Available for Purchase

Gotham Biotech's New Histoplasma Urinary Antigen EIA Kit Now Available for Purchase

The Gotham Biotech Histoplasma Urinary Antigen EIA is an enzyme immunoassay (EIA) intended to qualitatively detect the presence of Histoplasma capsulatum galactomannan antigen in human urine specimens. This kit, when used in conjunction with other diagnostic measures, can be used as an aid in the diagnosis of histoplasmosis. - September 08, 2023 - Gotham Biotech

Gateway Recruiting Launches Their First Life Sciences Marketing Salary Survey

Gateway Recruiting Launches Their First Life Sciences Marketing Salary Survey

Gateway Recruiting has launched a salary survey for Marketing professionals in Medical Device, Biotech, and Pharma sectors. Running from August 21st to October 6th, 2023, the survey aims to provide insights into compensation trends, internal equity, and industry changes, with participants receiving a complimentary report. - August 25, 2023 - Gateway Recruiting

Altucell Advances First-Ever Regulatory-Approved Human Islet Cell Encapsulation Therapy for Type 1 Diabetes

Altucell CEO Gary Harlem says this treatment could potentially eradicate the need for insulin and immunosuppressants. - August 22, 2023 - AltuCell Therapeutics

AMCI Now with Safe Torque Off (STO)

AMCI Now with Safe Torque Off (STO)

Advanced Micro Controls Inc. (AMCI), E2 products now with Safe Torque Off (STO)! Our space saving motion solutions are now available with built-in safety functionality. - August 21, 2023 - AMCI

Neurobit Launches Neurobit HUB: A Comprehensive Tool for Streamlining Sleep and Population Health Research

Neurobit Launches Neurobit HUB: A Comprehensive Tool for Streamlining Sleep and Population Health Research

Neurobit announces the launch of Neurobit HUB, a groundbreaking AI-driven tool for sleep and population health research. Integrating 40 sleep biomarkers, 20 health AI modules, and clinically validated devices, it's designed to streamline clinical trials, foster collaboration, and accelerate discoveries. A revolutionary step in sleep science. Learn more at https://www.neurobit.com/research/hub - August 14, 2023 - neurobit

Nordic Cold Chain Solutions Expands Testing and Lab Capabilities with New State-of-the-Art Chamber

Nordic Cold Chain Solutions Expands Testing and Lab Capabilities with New State-of-the-Art Chamber

Nordic Cold Chain Solutions, a leading provider of temperature-controlled packaging solutions, is excited to announce the expansion of its testing and lab capabilities with the addition of a new testing chamber. This equipment further strengthens Nordic Cold Chain Solutions' commitment to delivering top-quality products and ensuring the utmost reliability and performance for its customers. - August 10, 2023 - Nordic Cold Chain Solutions

Dr. Pam Gumbs Honored as a VIP Member by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized)

Dr. Pam Gumbs Honored as a VIP Member by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized)

Dr. Pam Gumbs of Berkeley, California has been honored as a VIP Member by P.O.WE.R. (Professional Organization of Women of Excellence Recognized) for her outstanding contributions and achievements in the pharmaceutical field. About Dr. Pam Gumbs Dr. Pam Gumbs is the owner and CEO of United... - August 09, 2023 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized

Addressing the Impact of Heat on Medications During Transportation: PMC Pharmacy Advocates for Private Hand Delivery to Safeguard Patient Safety

A key issue arising from this summer's record breaking heat waves is the effect on mail order medication that sits in hot mailboxes or porches. There is a solution and it's important for our most vulnerable residents, often dealing with chronic conditions, to follow the directions on their medication that they should be stored at 59 to 77 degrees °F in a cool, dry place. The solution is a local independent pharmacy. - July 22, 2023 - PMC Pharmacy

AMCI Sales Rep Territory Expands West

AMCI Sales Rep Territory Expands West

AMCI is expanding their coverage from coast to coast in order to manage the demand within the automation industry. Contour Motion, Inc. is now representing Advanced Micro Controls Inc. (AMCI) In California, Nevada, Arizona, and New Mexico. - July 20, 2023 - AMCI

Husson University’s July Summer Camps Offer Students the Opportunity to Explore Healthcare and Pharmacy

Two different science-oriented camps being held at Husson University this July will give high school students the opportunity to explore careers in pharmacy and healthcare. Sponsored by Husson University’s College of Health and Pharmacy, these camps are an outstanding way for students to... - July 13, 2023 - Husson University

PharmStars Announces Spring 2023 Accelerator Graduates: 13 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program

PharmStars Announces Spring 2023 Accelerator Graduates: 13 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program

PharmStars, the pharma-focused accelerator for digital health startups, announces that 13 startups have graduated from its Spring 2023 program focused on “Innovations in Women’s Health or Health Equity.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week program. PharmaU culminated with a Showcase Event, held in Boston in May, that brought together the participating startups and PharmStars’ innovation-minded pharma members. - June 20, 2023 - PharmStars

U.S. Congressman Mike Lawler Speaks to Pharmaceutical Execs Regarding Disparities in Marketing to Underserved Ethnic Minorities

U.S. Congressman Mike Lawler Speaks to Pharmaceutical Execs Regarding Disparities in Marketing to Underserved Ethnic Minorities

United States Congressman Michael Lawler delivered a message at the MMM Media Convene Conference: Multicultural Marketing: Pharma’s New Frontier. The Congressman cited the disparities in messaging to ethnic minorities by the pharmaceutical industry and called out government agencies for lack of oversight. - June 08, 2023 - Emerging Networks

PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator

PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars

Press Releases 1 - 50 of 2,698